Chinese Biotechs Edge Close To Bigger VC/PE Deals In November

 
• By Dexter Jie Yan

In addition to C-Ray Therapeutics’ $100m-plus series A+ round, Allink Biotherapeutics and IMPACT Therapeutics closed VC/PE-backed financing deals worth $42m and $34m, respectively. Other Chinese biotechs also sealed smaller deals.

funding
Chinese biotechs bagged bigger VC/PE-backed funding rounds in November. • Source: Shutterstock

More from Financing

More from Scrip